A Randomised, controlled trial to evaluate the safety and efficacy of oral rivaroxaban compared with the conservative treatment in patients with femoral neck fracture

Trial Profile

A Randomised, controlled trial to evaluate the safety and efficacy of oral rivaroxaban compared with the conservative treatment in patients with femoral neck fracture

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2017

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Deep vein thrombosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 28 Aug 2017 New trial record
    • 01 Jul 2017 Primary endpoint (Venous thromboembolism (VTE) defined as deep vein thrombosis (DVT) or pulmonary embolism (PE).) has been met, according to the results published in the Medicine
    • 01 Jul 2017 Results published in the Medicine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top